Cargando…

Evaluation of TS and ENOSF1 Variants as a Biomarker in Response to Neoadjuvant Chemotherapy based on 5FU in Gastric Cancer Patients

OBJECTIVE: Neoadjuvant chemotherapy with 5-fluorouracil (5FU) is one of the most effective treatment options for gastric cancer patients. However, treatment response varies significantly between patients based on their genetic profile. The purpose of this study was to determine the association betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arjmandi, Khadijeh, Ameli, Fereshteh, Salahshourifar, Iman, Esfandbod, Mohsen, Irani, Shiva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810307/ https://www.ncbi.nlm.nih.gov/pubmed/36172660 http://dx.doi.org/10.31557/APJCP.2022.23.9.2983

Ejemplares similares

High Frequency of Microsatellite Instability among Non-Metastatic Gastric Cancer
por: Fanaei, Khadijeh, et al.
Publicado: (2022)

HOTAIR Induces the Downregulation of miR-200 Family Members in Gastric Cancer Cell Lines
por: Bossaghzadeh, Fatemeh, et al.
Publicado: (2022)

An Evaluation of the Diagnostic Accuracy of a Panel of Variants in DPYD and a Single Variant in ENOSF1 for Predicting Common Capecitabine Related Toxicities
por: Palles, Claire, et al.
Publicado: (2021)

rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology
por: Kelemen, Linda E., et al.
Publicado: (2018)

Transient knockdown and overexpression reveal a developmental role for the zebrafish enosf1b gene
por: Finckbeiner, Steve, et al.
Publicado: (2011)

The Effect of Hormone Therapy on the Expression of Prostate Cancer and Multi-Epigenetic Marker Genes in a Population of Iranian Patients
por: Mohammadi, Mahan, et al.
Publicado: (2020)

Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review
por: Wang, Zhen, et al.
Publicado: (2012)

Clinical outcomes of TS-1 chemotherapy for advanced and recurrent gastric cancer
por: Lee, Sung Ryol, et al.
Publicado: (2011)

A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS
por: Rosmarin, Dan, et al.
Publicado: (2015)

GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS Axis in hepatocellular carcinoma
por: Gu, Yan-jiao, et al.
Publicado: (2015)

TS Gene Polymorphisms Are Not Good Markers of Response to 5-FU Therapy in Stage III Colon Cancer Patients
por: Fariña-Sarasqueta, A., et al.
Publicado: (2010)

ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients
por: Li, Ziyu, et al.
Publicado: (2016)

Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy
por: Li, Sheng, et al.
Publicado: (2014)

Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer
por: Shen, Jie, et al.
Publicado: (2014)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
por: Sun, Juan, et al.
Publicado: (2021)

E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy
por: Sulzyc-Bielicka, Violetta, et al.
Publicado: (2016)

A novel likely pathogenic variant in the FBXO32 gene associated with dilated cardiomyopathy according to whole‑exome sequencing
por: Ghasemi, Serwa, et al.
Publicado: (2022)

Molecular Marker Identification for Relapse Prediction in 5-FU-Based Adjuvant Chemotherapy in Gastric and Colorectal Cancers
por: Ishida, Kazushige, et al.
Publicado: (2012)

TS-1 add-on therapy in Japanese patients with triple-negative breast cancer after neoadjuvant or adjuvant chemotherapy: a feasibility study
por: Inoue, Kenichi, et al.
Publicado: (2019)

Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer
por: Hu, Shen-Bao, et al.
Publicado: (2019)

Perioperative versus total neoadjuvant chemotherapy in gastric cancer
por: Yang, Jessica, et al.
Publicado: (2023)

A Patient with a Large Gastric Tumor and Protein-Losing Gastroenteropathy Successfully Treated with Neoadjuvant TS-1 Combined with CDDP Therapy
por: Hashimoto, Tatsuya, et al.
Publicado: (2014)

Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
por: Reddavid, Rossella, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer
por: Tong, Xie, et al.
Publicado: (2023)

Response Evaluation after Neoadjuvant Chemotherapy for Resectable Gastric Cancer
por: Sandø, Alina Desiree, et al.
Publicado: (2023)

Genetic Polymorphism of GSTP1: Prediction of Clinical Outcome to Oxaliplatin/5-FU-based Chemotherapy in Advanced Gastric Cancer
por: Li, Qing-Fang, et al.
Publicado: (2010)

Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
por: Park, Ji Soo, et al.
Publicado: (2011)

Skeletal Muscle Quality and Quantity Affect Prognosis after Neoadjuvant Chemotherapy with a Triple Regimen of Docetaxel/Cisplatin/5-FU in Patients with Esophageal Cancer
por: Ito, Nobuhito, et al.
Publicado: (2023)

A Clinical Decision Support System for Increasing Compliance with Protocols in Chemotherapy of Children with Acute Lymphoblastic Leukemia
por: Moghaddasi, Hamid, et al.
Publicado: (2022)

The Study of rs693 and rs515135 in APOB in People with Familial Hypercholestrolemia
por: Karami, Fatemeh, et al.
Publicado: (2019)

Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer
por: CUI, HAI-BIN, et al.
Publicado: (2014)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

lncRNA HOTAIR Contributes to 5FU Resistance through Suppressing miR-218 and Activating NF-κB/TS Signaling in Colorectal Cancer
por: Li, Peilong, et al.
Publicado: (2017)

lncRNA HOTAIR Contributes to 5FU Resistance through Suppressing miR-218 and Activating NF-κB/TS Signaling in Colorectal Cancer
por: Li, Peilong, et al.
Publicado: (2020)

Association between Perceived Stress and Neutropenia in Patients with Leukemia under Chemotherapy
por: Esfandbod, Mohsen, et al.
Publicado: (2022)

Comparing the Effects of Melatonin and Zolpidem on Sleep Quality, Depression, and Anxiety in PatientsWithColorectalCancerUndergoingChemotherapy
por: Shahrokhi, Maryam, et al.
Publicado: (2021)

Neoadjuvant chemotherapy in locally advanced gastric adenocarcinoma: our experience in the elderly
por: Bugiantella, W, et al.
Publicado: (2009)

Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes
por: Liu, Yi, et al.
Publicado: (2018)

A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Yajing, et al.
Publicado: (2020)

Clinicopathological factors affecting the effect of neoadjuvant chemotherapy in patients with gastric cancer
por: Jiang, Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t7upcerhji8jek1utb2q2a8dh9